CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma

被引：0
|
作者：
Zeyana, Rivera [1 ]
Ferrone, Soldano [2 ,3 ,4 ]
Wang, Xinhui [2 ,3 ,4 ]
Sandro, Jube [1 ]
Yang, Haining [1 ]
Gaudino, Giovanni [1 ]
Carbone, Michele [1 ]
机构：
[1] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA
[2] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Pathol, Inst Canc, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2514
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
    Fenton, Moon
    Whiteside, Theresa L.
    Ferrone, Soldano
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2014, 22 (02) : 117 - 121
  • [42] CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
    Neelakshi Mungra
    Fleury A. N. Biteghe
    Zaria Malindi
    Allan M. Huysamen
    Maryam Karaan
    Natasha S. Hardcastle
    Rubina Bunjun
    Shivan Chetty
    Krupa Naran
    Dirk Lang
    Wolfgang Richter
    Roger Hunter
    Stefan Barth
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12203 - 12225
  • [43] Integrin-directed antibody-based immunotherapy: focus on VLA-4
    Savino, Wilson
    Chaves, Beatriz
    Bonomo, Adriana Cesar
    Cotta-de-Almeida, Vinicius
    IMMUNOTHERAPY ADVANCES, 2021, 1 (01):
  • [44] Allergooncology: Anti-cancer effects of an IgE antibody specific for the melanoma-associated antigen CSPG4
    Chauhan, J.
    Grandits, M.
    Palhares, L. C. G. F.
    Mele, S.
    Nakamura, M.
    Crescioli, S.
    Laddach, R.
    Romero-Clavijo, P.
    Geh, J. L. C.
    Ross, A. D. Mackenzie
    Tsoka, S.
    Karagiannis, P.
    Lacey, K. E.
    Spicer, J.
    Karagiannis, S. N.
    Bax, H. J.
    ALLERGY, 2023, 78 : 230 - 231
  • [45] Antibody-based therapeutic strategies for malignant lymphomas
    Ulrich Jaeger
    memo - Magazine of European Medical Oncology, 2009, 2 (Suppl 1) : 3 - 4
  • [46] Antibody-based therapeutic strategies for malignant lymphomas
    Jaeger, Ulrich
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 : 3 - 4
  • [47] IDENTIFICATION OF A SECRETED ONCOPROTEIN DKK1 AS A BIOMARKER AND A MOLECULAR TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY
    Daigo, Yataro
    Takano, Atsushi
    Sato, Nagato
    Nakamura, Yusuke
    ANNALS OF ONCOLOGY, 2010, 21 : 34 - 34
  • [48] Antibody-based treatment for mesothelioma: Clinical trials and laboratory studies
    Hassan, R.
    Zhang, J.
    Pastan, I.
    LUNG CANCER, 2006, 54 : S13 - S13
  • [49] Antibody-Based Approaches to Target Pancreatic Tumours
    Sorbara, Marie
    Cordelier, Pierre
    Bery, Nicolas
    ANTIBODIES, 2022, 11 (03)
  • [50] Biological impediments to monoclonal antibody-based cancer immunotherapy
    Christiansen, J
    Rajasekaran, AK
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (11) : 1493 - 1501
12345